Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol.
BACKGROUND
The treatment of secondary hyperparathyroidism (2 degrees HPT) associated with chronic renal failure adversely affects skeletal growth.


METHODS
We assessed epiphyseal growth plate morphology by quantitative histology and measured mRNA levels for selected markers of chondrocyte proliferation and differentiation by in situ hybridization in the growth plate cartilage of subtotally nephrectomized rats with either mild or advanced 2 degrees HPT.


RESULTS
The width of the growth plate cartilage in the proximal tibia and mRNA levels for PTH/PTHrP receptor were unchanged in rats with mild 2 degrees HPT, however, they were markedly less in nephrectomized rats with advanced 2 degrees HPT than in intact controls. Treatment with growth hormone 10 IU/kg/day increased growth plate thickness both in mild and in advanced 2 degrees HPT and raised mRNA levels for type II and type X collagen in rats with advanced 2 degrees HPT. The administration of calcitriol 50 ng/kg/day attenuated these responses in animals with advanced 2 degrees HPT. Overall, PTH/PTHrP receptor mRNA levels did not correspond to the serum levels of PTH indicating that PTH/PTHrP receptor expression is down-regulated in renal failure by a PTH-independent mechanism.


CONCLUSIONS
Calcitriol counteracts the trophic actions of growth hormone on epiphyseal growth plate cartilage and modifies chondrocyte differentiation in vivo, and these mechanisms may contribute to disturbances in longitudinal bone growth in renal failure.
Sanchez
C P
CP
Department of Pediatrics, UCLA School of Medicine, USA. csanchez@pediatrics.medsch.ucla.edu
Salusky
I B
IB
Kuizon
B D
BD
Abdella
P
P
Jüppner
H
H
Goodman
W G
WG
D000818:Animals; D001846:Bone Development / Q000502:physiology*; D002117:Calcitriol / Q000494:pharmacology / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D019902:Chondrocytes / Q000473:pathology; D003094:Collagen / Q000235:genetics; D013006:Growth Hormone / Q000494:pharmacology / Q000502:physiology*; D006132:Growth Plate / Q000187:drug effects / Q000473:pathology; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology*; D008297:Male; D009392:Nephrectomy / Q000379:methods; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone / Q000235:genetics; D013977:Tibia / Q000254:growth & development*
D012333:RNA, Messenger; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone; D013006:Growth Hormone; D003094:Collagen; D002117:Calcitriol